Ypsomed to increase production capacity

Press Releases Ypsomed Group

Burgdorf – The long-standing partnership between the French pharmaceutical group Sanofi and the Ypsomed Group will be bolstered by a new major project: starting in late 2016, Ypsomed plans to manufacture components for injection systems on an additional dedicated production line. The additional annual capacity will be in the double-digit millions.

Leer más...

New Chief Operating Officer in the Ypsomed Group

Press Releases Ypsomed Group

Burgdorf – Frank Mengis is to join the executive management of the Ypsomed Group in October 2015, assuming the role of Chief Operating Officer (COO). Mr. Mengis will succeed Dr Benjamin Reinmann, who is leaving the Burgdorf-based medical technology group at his own request.

Leer más...

Free float of Ypsomed registered shares increases to 25%

Press Releases Ypsomed Group

Burgdorf – Inclusion of Ypsomed in the Swiss Performance Index (SPI) within three months is possible. Over the past few days the quantity of Ypsomed registered shares freely available for trading on the SIX Swiss Exchange, the so-called free float, has exceeded 20% of the total stock of shares. If the free float consistently exceeds the lower limit of 20% over the next three months, then in accordance with the applicable regulations of the SIX Swiss Exchange, Ypsomed will once again be included in the Swiss Performance Index (SPI).

Leer más...

Ypsomed is expanding to China

Press Releases Ypsomed Group

Burgdorf – Intends to acquire new business in the area of injection systems.

Leer más...

Ypsomed demonstrates its commitment on World Diabetes Day

Press Releases Ypsomed Group

Burgdorf – "Blue Friday" at all Ypsomed locations worldwide: The Ypsomed Group, the leading developer and manufacturer of injection systems for self-medication and a diabetes specialist with global activities, is promoting public awareness of diabetes by conducting internal and external campaigns at each of its sites.

Leer más...